This Article Full Text Full Text (PDF) Correction (v117,pe302) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Vlahakes, G. J. Search for Related Content PubMed PubMed Citation Articles by Vlahakes, G. J. Related Collections Valvular heart disease CV surgery: valvular disease

(Circulation. 2007;116:1759-1760.)
© 2007 American Heart Association, Inc.

Editorial

Mechanical Heart Valves

The Test of Time...

Gus J. Vlahakes, MD

From the Harvard Medical School; Division of Cardiac Surgery, Massachusetts General Hospital, Boston, Mass.

Correspondence to Dr Gus J. Vlahakes, Professor of Surgery, Harvard Medical School; Division of Cardiac Surgery, Massachusetts General Hospital, 55 Fruit St, -COX652, Boston, MA 02114. E-mail vlahakes.gus@mgh.harvard.edu

Key Words: Editorials • follow-up studies • prosthesis • stenosis • surgery • valves

An extract of the first 250 words of the full text is provided, because this article has no abstract.

The report by Svennevig and colleagues in this issue of Circulation will stand as an important contribution to our knowledge of the outcomes after heart valve replacement.¹ This article, along with other extensive published series of patients followed up for as many as 4 decades after mechanical heart valve replacement, now help form the basis on which present and future decisions are made for patients with valvular heart disease.

Article p 1795

Decades ago, the properties of an ideal valve replacement were described by the late Dr Dwight Harken, a pioneer in cardiac surgery²; included in these properties are durability (at least as good as a native valve), no thrombogenicity (hence, warfarin anticoagulation not required), no inherent gradient, and easy to implant. How close a prosthetic heart valve approaches these ideals can only be determined after large numbers of implants, assiduous management of anticoagulation, complete patient follow-up, and the test of time... decades. Because mechanical aortic valves are generally implanted in younger patients, the interaction of the prosthesis with the patient, the propensity (or lack thereof) of tissue ingrowth that can interfere with valve function, the long-term structural integrity, and the thrombogenicity and relative resistance to variability in anticoagulation can only be determined with the patient population size and duration of thorough follow-up reported in this issue of Circulation for the Hall-Medtronic prosthesis, as well as in previous publications for other mechanical heart valves.

To date, no mechanical or bioprosthetic valve prosthesis has achieved the ideal profile described by . . . [Full Text of this Article]